GalaFlex Mesh in Facelift

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this post market study a resorbable mesh (GalaFLEX) will be used to reinforce the lifted and imbricated SMAS along the suture lines and spread the load of the SMAS along a greater surface area. GalaFLEX mesh is comprised of resorbable 4-hydroxybutyrate fibers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Emotional and Functional Benefits of Poly-L-Lactic Acid

NCT02613481

Facial Volume Loss

COMPLETED NA

CONFORM: Rotational Fractional Resection for Submental Contouring

NCT03407313

Skin Laxity Lipodystrophy

COMPLETED NA

Thread Lifting and Microfocused Ultrasound for Face Tightening Ultrasound for Lifting and Tightening the Face

NCT04157218

Skin Lifting and Tightening

UNKNOWN NA

Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma

NCT02892071

Melasma

WITHDRAWN PHASE1

Clinical Study to Evaluate Safety and Effectiveness of Noble Lift® Lifting Threads

NCT06454994

Aesthetic

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Superficial Musculoaponeurotic System (SMAS) Procedure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is able to understand the risks and benefits of participating in the study and must be willing to sign and date the Informed Consent Form for this study approved by the Institutional Review Board (IRB.)
* Be at least 21 years of age.
* Be willing and able to comply with the requirements of the protocol.
* Be willing to refrain from participating in any other investigational interventional study while enrolled in this study.
* Female subjects must have a negative pregnancy test within the last 24 hours timeline and have no intentions of becoming pregnant during participation in the study, or be sterilized.

Exclusion Criteria

* Subject is unwilling or unable to give written consent to participate in the investigation or unable to comply with the requirements of the protocol.
* Subject has known severe allergies manifested by a history of anaphylaxis, or history or presence of severe multiple allergies.
* Subject has any serious skin disease, e.g., Eczema and psoriasis of the face, severe rosacea, scleroderma, local infections and severe acne.
* Subjects has diabetes, coagulation disorders, connective tissue disorders, lipodystrophy, or other serious systemic disease.
* Active herpes labialis
* Subject is infected with HIV and/or received or may receive immunosuppressive therapy over the course of the study (such as rheumatoid arthritis).
* Received any experimental drug or device within the previous three months.
* Known alcohol or drug abuser.
* Female subject who is pregnant or lactating or intending to become pregnant during the period of the study, or who would not use an adequate method of contraception (contraceptive pill, intra-uterine device) for the duration of the study.
* Possesses any psychological condition, or is under treatment for any condition which, in the opinion of the Investigator and/or consulting physicians(s),would constitute an unwarranted risk.
* Presents with severe jowling or severe cervical skin redundancy.
* Subject is currently a smoker or is a prior smoker who quit in the last 12 months.
* Active abscess or infection
* Currently involved with claims for, or is accepting, workers compensation
* Currently engaged in medical malpractice litigation.

Minimum Eligible Age

21 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No